Details of Host Protein-DME Interaction (HOSPPI)
| General Information of Drug-Metabolizing Enzyme (DME ID: DME0067) | |||||
|---|---|---|---|---|---|
| DME Name | NADPH-dependent carbonyl reductase 1 (CBR1), Homo sapiens | DME Info | |||
| UniProt ID | |||||
| EC Number | EC: 1.1.1.184 (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
| Interactome | |||||
| Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
|---|---|---|---|---|---|
| ICD Disease Classification 02 Neoplasms | |||||
| ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Oligodendroglial tumour | Significant hypermethylation | |||
| Interaction Name | DNMT-CBR1 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 4.27E-12; delta-beta: 5.41E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CBR1 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme NADPH-dependent carbonyl reductase 1. As a result, the interaction between DNMT and CBR1 can significantly affect the drug-metabolizing process of NADPH-dependent carbonyl reductase 1. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| DNA methyltransferase (DNMT) | Oligodendroglioma | Significant hypermethylation | |||
| Interaction Name | DNMT-CBR1 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 1.89E-34; delta-beta: 5.39E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CBR1 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme NADPH-dependent carbonyl reductase 1. As a result, the interaction between DNMT and CBR1 can significantly affect the drug-metabolizing process of NADPH-dependent carbonyl reductase 1. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Lymphoma | Significant hypermethylation | |||
| Interaction Name | DNMT-CBR1 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 3.57E-13; delta-beta: 5.10E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CBR1 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme NADPH-dependent carbonyl reductase 1. As a result, the interaction between DNMT and CBR1 can significantly affect the drug-metabolizing process of NADPH-dependent carbonyl reductase 1. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.